Bodyport is a digital health company transforming how heart health is monitored and managed through a simple, non-invasive smart scale. Designed to support patients with chronic cardiovascular conditions such as heart failure, Bodyport’s platform uses biomarker detection and AI analysis to provide early warnings of fluid retention and cardiac deterioration.
The Bodyport Cardiac Scale enables patients to monitor their heart health at home with the ease of stepping on a scale. This one-step measurement passively captures a wide range of cardiovascular biomarkers, offering a more complete picture of heart health compared to traditional scales or weight monitoring.
With AI-powered alerts and clinician dashboards, Bodyport helps care teams act earlier, reduce hospitalizations, and better manage chronic conditions remotely. The solution enhances the effectiveness of remote patient monitoring and supports value-based care models by providing actionable, predictive insights.
Features
Cardiac-Optimized Smart Scale: Bodyport’s scale passively collects key cardiovascular biomarkers such as fluid status, heart rate, cardiac output estimates, and more—all from a patient’s bare feet in under 30 seconds.
Non-Invasive and Easy to Use: The device requires no wires, patches, or wearables. Patients simply step on the scale, making it highly user-friendly and improving adherence.
AI-Powered Cardiac Insights: Bodyport’s machine learning models analyze collected data to detect early signs of worsening heart conditions, such as fluid retention or hemodynamic instability.
Early Intervention Alerts: The platform sends alerts to clinicians based on changes in a patient’s cardiac status, allowing for earlier interventions to prevent complications or hospital readmissions.
Clinician Dashboard: Healthcare providers access a secure portal that presents longitudinal trends, risk scores, and patient-specific alerts to support proactive care.
Patient Engagement Tools: Patients receive tailored feedback, encouragement, and education through a mobile app designed to improve engagement and understanding of their health.
Seamless Remote Monitoring: Bodyport supports remote care workflows by delivering consistent, real-time insights without additional burden on patients or clinicians.
Integration Support: Bodyport integrates with care management platforms and EHR systems to streamline clinician workflows and data sharing.
HIPAA-Compliant Security: All patient data is encrypted and protected in accordance with U.S. healthcare privacy laws and industry standards.
How It Works
The Bodyport platform begins with the Cardiac Scale, which patients use daily at home. As patients step on the scale, it collects cardiovascular signals from the feet using sensors embedded in the platform. These signals include bioimpedance, heart rate, and other indicators associated with fluid balance and cardiac performance.
The raw signals are transmitted securely to Bodyport’s cloud-based analytics engine. Here, machine learning models analyze the data, detect deviations from each patient’s baseline, and generate insights about fluid retention, cardiac strain, or early decompensation.
Clinicians are notified through a web-based dashboard if a patient’s measurements indicate risk, enabling timely intervention. This reduces the reliance on lagging indicators like weight gain alone, which can miss early signs of heart failure progression.
Patients receive notifications and educational messages through the Bodyport mobile app, which helps them stay engaged and adhere to care plans without requiring technical expertise or additional effort.
Use Cases
Cardiology clinics use Bodyport to manage heart failure patients remotely, identifying early warning signs before symptoms worsen.
Hospital systems deploy Bodyport post-discharge to monitor high-risk cardiac patients at home and reduce 30-day readmission rates.
Primary care physicians use Bodyport as part of a chronic disease management program to track patients with comorbid cardiovascular risks.
Accountable care organizations integrate Bodyport into their population health platforms to support value-based care and improve outcomes.
Home health agencies equip patients with Bodyport to provide continuous monitoring without the need for complex equipment or nurse visits.
Clinical researchers use Bodyport’s scalable platform to gather real-world cardiac biomarker data for studies focused on heart failure and remote monitoring effectiveness.
Pricing
Bodyport does not publicly list specific pricing on its website. The platform is offered primarily to healthcare organizations, including hospitals, health systems, payers, and research institutions through customized enterprise agreements.
Pricing is typically based on:
Number of enrolled patients
Features and integration level
Clinical support services included
Data access and reporting tools
Interested organizations can request a customized quote and demo through Bodyport’s sales team via the official website.
Strengths
Bodyport offers a novel and non-invasive method to monitor heart health using a familiar form factor—a bathroom scale—which reduces barriers to adoption and improves patient compliance.
Its focus on cardiovascular-specific biomarkers, beyond weight, sets it apart from standard RPM tools and provides deeper insights for clinical decision-making.
The AI engine enables early detection of health decline, giving clinicians more time to act before hospitalization is required.
The simplicity of use, without wearables or patches, makes the solution ideal for elderly or high-risk patients who might struggle with complex monitoring systems.
Bodyport supports both proactive population health management and individual chronic care programs, helping organizations meet quality and outcome-based care goals.
Clinicians benefit from clear, actionable dashboards that streamline their workflow rather than adding complexity.
Drawbacks
Bodyport’s solution is currently focused on cardiovascular conditions, particularly heart failure, which may limit its application outside these areas.
As a B2B platform, it is not available for direct consumer purchase or use without being part of a care program or provider organization.
Initial integration with clinical systems may require IT coordination and workflow adjustments, especially in organizations without established RPM infrastructure.
While patient adherence is higher than with wearables, it still depends on daily engagement for optimal results.
Since pricing is not publicly disclosed, smaller providers may need to inquire directly to assess affordability and deployment feasibility.
Comparison with Other Tools
Bodyport can be compared to traditional remote patient monitoring tools like weight scales, blood pressure cuffs, and cardiac implantable devices, as well as modern RPM platforms like Biofourmis and Current Health.
Unlike standard scales that monitor only weight, Bodyport captures advanced cardiac signals and uses AI to interpret them, offering more proactive care than simple trend tracking.
Compared to Biofourmis, which uses wearable sensors for continuous monitoring, Bodyport offers a less intrusive and easier-to-use device for patients, while still delivering actionable insights.
Current Health offers a full hospital-at-home RPM platform with multi-sensor wearables. Bodyport, in contrast, provides a single, low-effort entry point focused on heart health, making it easier to deploy at scale for specific patient populations.
Bodyport’s simplicity, combined with its cardiovascular specificity, makes it ideal for organizations looking to enhance chronic cardiac care without complex device management.
Customer Reviews and Testimonials
While Bodyport does not feature traditional customer reviews on its website, it highlights clinical partnerships and pilot programs with leading healthcare systems and research organizations.
Health professionals and researchers have praised Bodyport’s ability to capture fluid changes earlier than weight-based monitoring alone, leading to better care decisions and fewer hospitalizations.
Early users report improved patient satisfaction due to the ease of use, and clinicians appreciate the ability to monitor at-risk patients without adding workload.
Peer-reviewed publications and presentations at cardiovascular health conferences have acknowledged Bodyport’s clinical relevance and innovation in remote monitoring.
Organizations interested in testimonials or implementation results are encouraged to contact Bodyport directly for case studies or references.
Conclusion
Bodyport is transforming remote cardiac care by offering a simple yet highly intelligent platform that combines a cardiac-optimized smart scale with AI-powered analytics. Its non-invasive approach to collecting rich cardiovascular data allows care teams to detect problems earlier, reduce hospitalizations, and support patients in managing chronic conditions at home.
With its focus on heart failure and fluid management, Bodyport stands out in the remote monitoring space as a targeted, effective, and scalable solution. By bridging the gap between patient adherence and clinical insight, it supports a more proactive, preventative model of care.
For healthcare organizations aiming to reduce cardiac-related readmissions and optimize remote care programs, Bodyport offers a proven and innovative path forward
